Moriou_2021_Mar.Drugs_19_

Reference

Title : Bioactive Bromotyrosine Derivatives from the Pacific Marine Sponge Suberea clavata (Pulitzer-Finali, 1982) - Moriou_2021_Mar.Drugs_19_
Author(s) : Moriou C , Lacroix D , Petek S , El-Demerdash A , Trepos R , Leu TM , Florean C , Diederich M , Hellio C , Debitus C , Al-Mourabit A
Ref : Mar Drugs , 19 : , 2021
Abstract :

Chemical investigation of the South-Pacific marine sponge Suberea clavata led to the isolation of eight new bromotyrosine metabolites named subereins 1-8 (2-9) along with twelve known co-isolated congeners. The detailed configuration determination of the first representative major compound of this family 11-epi-fistularin-3 (11R,17S) (1) is described. Their chemical characterization was achieved by HRMS and integrated 1D and 2D NMR (nuclear magnetic resonance) spectroscopic studies and extensive comparison with literature data. For the first time, a complete assignment of the absolute configurations for stereogenic centers C-11/17 of the known members (11R,17S) 11-epi-fistularin-3 (1) and 17-deoxyfistularin-3 (10) was determined by a combination of chemical modifications, Mosher's technology, and ECD spectroscopy. Consequently, the absolute configurations of all our new isolated compounds 2-9 were determined by the combination of NMR, Mosher's method, ECD comparison, and chemical modifications. Interestingly, compounds 2-7 were obtained by chemical transformation of the major compound 11-epi-fistularin-3 (1). Evaluation for acetylcholinesterase inhibition (AChE), DNA methyltransferase 1 (DNMT1) modulating activity and antifouling activities using marine bacterial strains are also presented.

PubMedSearch : Moriou_2021_Mar.Drugs_19_
PubMedID: 33800819

Related information

Citations formats

Moriou C, Lacroix D, Petek S, El-Demerdash A, Trepos R, Leu TM, Florean C, Diederich M, Hellio C, Debitus C, Al-Mourabit A (2021)
Bioactive Bromotyrosine Derivatives from the Pacific Marine Sponge Suberea clavata (Pulitzer-Finali, 1982)
Mar Drugs 19 :

Moriou C, Lacroix D, Petek S, El-Demerdash A, Trepos R, Leu TM, Florean C, Diederich M, Hellio C, Debitus C, Al-Mourabit A (2021)
Mar Drugs 19 :